Travere Therapeutics, Inc.

NasdaqGM:TVTX Stock Report

Market Cap: US$3.1b

Travere Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TVTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Sep 25SellUS$8,263Christopher ClineIndividual454US$18.20
11 Apr 25SellUS$631Christopher ClineIndividual48US$13.14
03 Feb 25SellUS$103,940Peter HeermaIndividual5,166US$20.12
03 Feb 25SellUS$84,645Jula InrigIndividual4,207US$20.12
03 Feb 25SellUS$104,463Christopher ClineIndividual5,192US$20.12
03 Feb 25SellUS$67,362Sandra CalvinIndividual3,348US$20.12
22 Jan 25SellUS$17,520Sandra CalvinIndividual925US$18.94
22 Jan 25SellUS$16,384Christopher ClineIndividual865US$18.94
22 Jan 25SellUS$30,002Peter HeermaIndividual1,584US$18.94
03 Jan 25SellUS$39,461Jula InrigIndividual2,066US$19.10

Insider Trading Volume

Insider Buying: TVTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TVTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders972,8100.879%
VC/PE Firms4,495,6154.06%
Hedge Funds8,876,0008.02%
Institutions96,276,39387%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 85.6% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.7%
Janus Henderson Group plc
11,339,864US$398.7m18.9%0.14%
9.92%
Armistice Capital LLC
8,876,000US$312.1m0.05%8.16%
9.13%
BlackRock, Inc.
8,168,951US$287.2m-0.26%no data
6.7%
The Vanguard Group, Inc.
5,994,283US$210.8m19.6%no data
5.7%
Macquarie Investment Management Business Trust
5,097,482US$179.2m6.26%0.22%
5.02%
Perceptive Advisors LLC
4,495,615US$158.1m439%4.2%
3.89%
State Street Global Advisors, Inc.
3,483,176US$122.5m-4.48%no data
3.74%
Emerald Advisers, LLC
3,347,709US$117.7m3.55%2.23%
3.11%
Adage Capital Management, L.P.
2,784,000US$97.9m27.4%0.15%
2.79%
Renaissance Technologies LLC
2,495,114US$87.7m-7.68%0.11%
2.24%
Geode Capital Management, LLC
2,003,701US$70.4m1.37%no data
2.13%
Rock Springs Capital Management LP
1,908,208US$67.1m-34.7%3.22%
1.82%
HBM Partners Ltd.
1,627,150US$57.2m0%4.72%
1.79%
Stephens Investment Management Group, LLC
1,599,668US$56.2m0%0.72%
1.72%
Kynam Capital Management, LP
1,540,691US$54.2m-14.5%3.96%
1.61%
Morgan Stanley
1,436,790US$50.5m-2.41%no data
1.47%
Eversept Partners, L.P.
1,315,033US$46.2m61.1%3.85%
1.45%
The Goldman Sachs Group, Inc.
1,298,869US$45.7m0%0.02%
1.3%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,165,415US$41.0m-2.5%0.01%
1.29%
RA Capital Management, L.P.
1,150,000US$40.4m0%0.41%
1.26%
D. E. Shaw & Co., L.P.
1,130,750US$39.8m-34%0.04%
1.22%
UBS Asset Management AG
1,095,838US$38.5m42%no data
1.21%
Jennison Associates LLC
1,084,350US$38.1m40.5%0.02%
1.21%
Bank of America Corporation
1,079,133US$37.9m223%0.01%
1.19%
FMR LLC
1,067,605US$37.5m-1.11%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 14:26
End of Day Share Price 2025/10/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Travere Therapeutics, Inc. is covered by 31 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guyn KimBMO Capital Markets Equity Research
Jason ZemanskyBofA Global Research
Dae Gon HaBTIG